Latest Intelligence on Therapy Area in Croatia

Select information type

Refine your search

Search tips

Published within

« | 1 | » »|

Type Product title / description Pub Price

GlaxoSmithKline: Pliva deal to boost R&D

GlaxoSmithKline has entered into a deal to buy Pliva's state-of-the-art R&D facility Pliva-Istrazivacki Institut. Having recently reported an annual profit of GBP6.7 billion, Europe's biggest drugmaker will now hope to improve this financial performance by moving its research activities to lower-cost emerging markets.

Published By Datamonitor
15 Feb 2006

« | 1 | » »|

No help is available.